glp-1 and gip Frontiers TrimRX | GLP-1 vs GIP:

In crude analyses, GLP-1 receptor agonist use was associated with an increased incidence of suicidality compared with DPP-4 inhibitors (crude incidence rates 3.9 v 1.8 per 1000 person years, respectively

FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) are commercially available

What surprised me most was my skin

Learn proper refrigeration requirements before and after opening, what happens if storage guidelines are breached, and how to travel safely with GLP-1 medications in the UK.

The battle over America's booming weight-loss drug market has a significant update, with a move thats likely to cause a shift across the healthcare and corporate benefits landscape: Cigna, one of Americas biggest insurers, is dropping coverage for GLP-1 obesity drugs, even for its own staff

GLP-1 receptor agonists emerged from decades of diabetes research before revolutionizing weight management in the 2020s